Low‐dose tofacitinib with 308‐nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo. (1st April 2022)

Record Type:: Journal Article
Title:: Low‐dose tofacitinib with 308‐nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo. (1st April 2022)
Main Title:: Low‐dose tofacitinib with 308‐nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo
Authors:: Fang, Wei‐Cheng
Lin, Sheng‐Yiao
Huang, Shu‐Mei
Lan, Cheng‐Che E.
Abstract:: Abstract: Combining low‐dose tofacitinib with 308‐nm excimer may be an effective treatment for patients with nonsegmental vitiligo who were refractory to conventional therapies.
Is Part Of:: Clinical and experimental dermatology. Volume 47:Number 4(2022)
Journal:: Clinical and experimental dermatology
Issue:: Volume 47:Number 4(2022)
Issue Display:: Volume 47, Issue 4 (2022)
Year:: 2022
Volume:: 47
Issue:: 4
Issue Sort Value:: 2022-0047-0004-0000
Page Start:: 782
Page End:: 783
Publication Date:: 2022-04-01
Subjects:: Skin -- Diseases -- Periodicals
616.5
Journal URLs:: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2230 ↗
https://academic.oup.com/ced/issue ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/ced.15070 ↗
Languages:: English
ISSNs:: 0307-6938
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3286.250000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 25498.xml